Pain Management through Neurocognitive Therapeutic Exercises in Hypermobile Ehlers-Danlos Syndrome Patients with Chronic Low Back Pain.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
12
2020
accepted:
21
05
2021
entrez:
14
6
2021
pubmed:
15
6
2021
medline:
23
9
2021
Statut:
epublish
Résumé
The hypermobile type of Ehlers-Danlos syndrome (hEDS) is likely the most common hereditary disorder of connective tissue mainly characterized by joint hypermobility. Patients with hEDS suffer joint pain, in particular low back pain, commonly resistant to drug therapy. The aim of this research was to evaluate a neurocognitive rehabilitation approach based not only on the motion and function recovery but also on the pain management. In this nonrandomized clinical trial, eighteen hEDS patients (4 males and 14 females) with mean age 21 years (range 13-55) were recruited and evaluated before and after three months of rehabilitation treatment. The outcome scores showed significant statistical results after treatment in reducing pain symptoms (numerical rating scale, The clinical results observed in our study seem to confirm the role of a specific neurocognitive rehabilitation program in the chronic pain management in the Ehlers-Danlos syndrome; the rehabilitation treatment should be tailored on patient problems and focused not only in the recovery of movement but also on pain perception.
Sections du résumé
BACKGROUND
BACKGROUND
The hypermobile type of Ehlers-Danlos syndrome (hEDS) is likely the most common hereditary disorder of connective tissue mainly characterized by joint hypermobility. Patients with hEDS suffer joint pain, in particular low back pain, commonly resistant to drug therapy. The aim of this research was to evaluate a neurocognitive rehabilitation approach based not only on the motion and function recovery but also on the pain management.
METHODS
METHODS
In this nonrandomized clinical trial, eighteen hEDS patients (4 males and 14 females) with mean age 21 years (range 13-55) were recruited and evaluated before and after three months of rehabilitation treatment.
RESULTS
RESULTS
The outcome scores showed significant statistical results after treatment in reducing pain symptoms (numerical rating scale,
CONCLUSION
CONCLUSIONS
The clinical results observed in our study seem to confirm the role of a specific neurocognitive rehabilitation program in the chronic pain management in the Ehlers-Danlos syndrome; the rehabilitation treatment should be tailored on patient problems and focused not only in the recovery of movement but also on pain perception.
Identifiants
pubmed: 34124258
doi: 10.1155/2021/6664864
pmc: PMC8189767
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6664864Informations de copyright
Copyright © 2021 Claudia Celletti et al.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Clin J Pain. 2000 Sep;16(3 Suppl):S144-56
pubmed: 11014459
J Neurol Phys Ther. 2017 Jul;41(3):164-172
pubmed: 28628550
Pain. 1975 Sep;1(3):277-299
pubmed: 1235985
Spine (Phila Pa 1976). 2010 May 20;35(12):1241-6
pubmed: 20216338
J Phys Ther Sci. 2017 Apr;29(4):665-672
pubmed: 28533607
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
J Pain Symptom Manage. 2011 Jan;41(1):e2-4
pubmed: 21145199
Eur J Phys Rehabil Med. 2014 Feb;50(1):67-72
pubmed: 24622048
Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952
pubmed: 11074683
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):212-219
pubmed: 28186390
Pain. 2017 Apr;158 Suppl 1:S2-S10
pubmed: 27875480
Eur J Pain. 2016 Sep;20(8):1319-25
pubmed: 26919608
Musculoskeletal Care. 2017 Dec;15(4):413-421
pubmed: 28371175
Am J Med Genet. 1988 Mar;29(3):581-94
pubmed: 3287925
Pain. 2011 Mar;152(3 Suppl):S2-S15
pubmed: 20961685
Pain. 2007 Jan;127(1-2):42-51
pubmed: 16962238
BMJ Open. 2016 Jul 14;6(7):e011220
pubmed: 27417197
Anesth Analg. 2007 May;104(5):1223-9, tables of contents
pubmed: 17456678
Clin Ter. 2013;164(4):e325-35
pubmed: 24045532
Pain Physician. 2014 Sep-Oct;17(5):447-57
pubmed: 25247901
Pain Physician. 2015 May-Jun;18(3):E333-46
pubmed: 26000680
Disabil Rehabil. 2017 May;39(10):994-1001
pubmed: 27215948
Clin Rheumatol. 2007 Apr;26(4):465-73
pubmed: 17115100
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):48-69
pubmed: 28145611
Am J Med Genet. 1998 Apr 28;77(1):31-7
pubmed: 9557891
Eur J Phys Rehabil Med. 2014 Jun;50(3):255-64
pubmed: 24429918
Biomed Res Int. 2013;2013:580460
pubmed: 23936820
Pain. 1988 Feb;32(2):133-139
pubmed: 3283659
Man Ther. 2003 Aug;8(3):130-40
pubmed: 12909433
Prog Brain Res. 2018;240:141-159
pubmed: 30390828
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26
pubmed: 28306229
Eur J Pain. 2004 Aug;8(4):283-91
pubmed: 15207508
Eur Spine J. 2003 Feb;12(1):12-20
pubmed: 12592542